ID

19069

Description

CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00075192

Lien

https://clinicaltrials.gov/show/NCT00075192

Mots-clés

Versions (1)
  1. 03/12/2016 03/12/2016 -
Téléchargé le

3 décembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostatic Neoplasms NCT00075192

Anglais

Eligibility Prostatic Neoplasms NCT00075192

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed adenocarcinoma of the prostate, previously untreated
Description

Adenocarcinoma of prostate untreated

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007112
UMLS CUI [1,2]
C0332155
potential candidate for radical prostatectomy on the basis of the patient's general medical condition, performance status, and life expectancy
Description

Indication Radical prostatectomy | General physical condition | performance status | Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0194810
UMLS CUI [2]
C1142435
UMLS CUI [3]
C1518965
UMLS CUI [4]
C0023671
potential candidate for nht prior to prostatectomy, including high or intermediate risk of recurrence, based on an estimated risk of biochemical recurrence: high risk category: psa >20 or gleason score 8 or ct2c/ct3 or intermediate risk category: psa >10 and d20 or gleason score 7 or ct2b
Description

Indication Hormone Therapy Neoadjuvant | Prostatectomy | Recurrence Risk High | Recurrence Risk Intermediate | PSA Failure Risk Estimated | Prostate specific antigen measurement | Gleason score | TNM clinical staging

Type de données

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0279025
UMLS CUI [1,3]
C0600558
UMLS CUI [2]
C0033573
UMLS CUI [3,1]
C2986492
UMLS CUI [3,2]
C0205250
UMLS CUI [4,1]
C2986492
UMLS CUI [4,2]
C0205103
UMLS CUI [5,1]
C2985506
UMLS CUI [5,2]
C0035647
UMLS CUI [5,3]
C0750572
UMLS CUI [6]
C0201544
UMLS CUI [7]
C3203027
UMLS CUI [8]
C3258246
no evidence of metastatic disease by physical examination, bone scan, and computed tomography, or mri, of the abdomen and pelvis
Description

Neoplasm Metastasis Evidence of | Physical Examination Abdomen | Scan of bone Abdomen | CT of abdomen | MRI of abdomen | Physical Examination Pelvis | Scan of bone Pelvis | CT of Pelvis | MRI of Pelvis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0332120
UMLS CUI [2,1]
C0031809
UMLS CUI [2,2]
C0000726
UMLS CUI [3,1]
C0203668
UMLS CUI [3,2]
C0000726
UMLS CUI [4]
C0412620
UMLS CUI [5]
C0412693
UMLS CUI [6,1]
C0031809
UMLS CUI [6,2]
C0030797
UMLS CUI [7,1]
C0203668
UMLS CUI [7,2]
C0030797
UMLS CUI [8]
C0412628
UMLS CUI [9]
C0203201
age > 18 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status 0-1
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
adequate bone marrow, hepatic, and renal function determined within 2 weeks prior to starting therapy
Description

Bone Marrow function | Liver function | Renal function

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
availability of prostatectomy specimen for histological analysis at the armed forces institute of pathology
Description

Prostatectomy Specimen Availability

Type de données

boolean

Alias
UMLS CUI [1,1]
C0033573
UMLS CUI [1,2]
C0370003
UMLS CUI [1,3]
C0470187
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior hormone therapy, radiation, chemotherapy, or immunologic therapy for prostate cancer
Description

Hormone Therapy Prostate carcinoma | Therapeutic radiology procedure Prostate carcinoma | Chemotherapy Prostate carcinoma | Immunotherapy Prostate carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C0600139
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0600139
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C0600139
UMLS CUI [4,1]
C0021083
UMLS CUI [4,2]
C0600139
history of, or significant risk for, chronic inflammatory or autoimmune disease
Description

Chronic inflammatory disorder Risk Significant | Autoimmune Disease Risk Significant

Type de données

boolean

Alias
UMLS CUI [1,1]
C1290886
UMLS CUI [1,2]
C0035647
UMLS CUI [1,3]
C0750502
UMLS CUI [2,1]
C0004364
UMLS CUI [2,2]
C0035647
UMLS CUI [2,3]
C0750502
potential requirement for systemic corticosteroids before surgery based on prior history
Description

Operative Surgical Procedures | Adrenal Cortex Hormones Systemic Patient need for

Type de données

boolean

Alias
UMLS CUI [1]
C0543467
UMLS CUI [2,1]
C0001617
UMLS CUI [2,2]
C0205373
UMLS CUI [2,3]
C0686904
history of autoimmune colitis or chronic gi conditions associated with diarrhea or bleeding, or current acute colitis of any origin
Description

Autoimmune colitis | Gastrointestinal Diseases chronic | Diarrhea | Hemorrhage | Colitis

Type de données

boolean

Alias
UMLS CUI [1]
C3888552
UMLS CUI [2,1]
C0017178
UMLS CUI [2,2]
C0205191
UMLS CUI [3]
C0011991
UMLS CUI [4]
C0019080
UMLS CUI [5]
C0009319
any serious uncontrolled medical disorder or active infection which would impair ability to receive study treatment and subsequent prostatectomy
Description

Disease Uncontrolled Serious Affecting Investigational Therapy | Communicable Disease Affecting Investigational Therapy | Disease Uncontrolled Serious Affecting Prostatectomy | Communicable Disease Affecting Prostatectomy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205318
UMLS CUI [1,3]
C0205404
UMLS CUI [1,4]
C0392760
UMLS CUI [1,5]
C0949266
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0949266
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0205318
UMLS CUI [3,3]
C0205404
UMLS CUI [3,4]
C0392760
UMLS CUI [3,5]
C0033573
UMLS CUI [4,1]
C0009450
UMLS CUI [4,2]
C0392760
UMLS CUI [4,3]
C0033573
coexisting malignancies except basal or squamous cell carcinoma of the skin
Description

Malignant Neoplasms | Basal cell carcinoma | Squamous cell carcinoma of skin

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0553723
Retour au début de la page

Similar models

Eligibility Prostatic Neoplasms NCT00075192

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate untreated
Item
histologically confirmed adenocarcinoma of the prostate, previously untreated
boolean
C0007112 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Indication Radical prostatectomy | General physical condition | performance status | Life Expectancy
Item
potential candidate for radical prostatectomy on the basis of the patient's general medical condition, performance status, and life expectancy
boolean
C3146298 (UMLS CUI [1,1])
C0194810 (UMLS CUI [1,2])
C1142435 (UMLS CUI [2])
C1518965 (UMLS CUI [3])
C0023671 (UMLS CUI [4])
Indication Hormone Therapy Neoadjuvant | Prostatectomy | Recurrence Risk High | Recurrence Risk Intermediate | PSA Failure Risk Estimated | Prostate specific antigen measurement | Gleason score | TNM clinical staging
Item
potential candidate for nht prior to prostatectomy, including high or intermediate risk of recurrence, based on an estimated risk of biochemical recurrence: high risk category: psa >20 or gleason score 8 or ct2c/ct3 or intermediate risk category: psa >10 and d20 or gleason score 7 or ct2b
boolean
C3146298 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0600558 (UMLS CUI [1,3])
C0033573 (UMLS CUI [2])
C2986492 (UMLS CUI [3,1])
C0205250 (UMLS CUI [3,2])
C2986492 (UMLS CUI [4,1])
C0205103 (UMLS CUI [4,2])
C2985506 (UMLS CUI [5,1])
C0035647 (UMLS CUI [5,2])
C0750572 (UMLS CUI [5,3])
C0201544 (UMLS CUI [6])
C3203027 (UMLS CUI [7])
C3258246 (UMLS CUI [8])
Neoplasm Metastasis Evidence of | Physical Examination Abdomen | Scan of bone Abdomen | CT of abdomen | MRI of abdomen | Physical Examination Pelvis | Scan of bone Pelvis | CT of Pelvis | MRI of Pelvis
Item
no evidence of metastatic disease by physical examination, bone scan, and computed tomography, or mri, of the abdomen and pelvis
boolean
C0027627 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0031809 (UMLS CUI [2,1])
C0000726 (UMLS CUI [2,2])
C0203668 (UMLS CUI [3,1])
C0000726 (UMLS CUI [3,2])
C0412620 (UMLS CUI [4])
C0412693 (UMLS CUI [5])
C0031809 (UMLS CUI [6,1])
C0030797 (UMLS CUI [6,2])
C0203668 (UMLS CUI [7,1])
C0030797 (UMLS CUI [7,2])
C0412628 (UMLS CUI [8])
C0203201 (UMLS CUI [9])
Age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, hepatic, and renal function determined within 2 weeks prior to starting therapy
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Prostatectomy Specimen Availability
Item
availability of prostatectomy specimen for histological analysis at the armed forces institute of pathology
boolean
C0033573 (UMLS CUI [1,1])
C0370003 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Hormone Therapy Prostate carcinoma | Therapeutic radiology procedure Prostate carcinoma | Chemotherapy Prostate carcinoma | Immunotherapy Prostate carcinoma
Item
prior hormone therapy, radiation, chemotherapy, or immunologic therapy for prostate cancer
boolean
C0279025 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C0600139 (UMLS CUI [3,2])
C0021083 (UMLS CUI [4,1])
C0600139 (UMLS CUI [4,2])
Chronic inflammatory disorder Risk Significant | Autoimmune Disease Risk Significant
Item
history of, or significant risk for, chronic inflammatory or autoimmune disease
boolean
C1290886 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
C0004364 (UMLS CUI [2,1])
C0035647 (UMLS CUI [2,2])
C0750502 (UMLS CUI [2,3])
Operative Surgical Procedures | Adrenal Cortex Hormones Systemic Patient need for
Item
potential requirement for systemic corticosteroids before surgery based on prior history
boolean
C0543467 (UMLS CUI [1])
C0001617 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])
Autoimmune colitis | Gastrointestinal Diseases chronic | Diarrhea | Hemorrhage | Colitis
Item
history of autoimmune colitis or chronic gi conditions associated with diarrhea or bleeding, or current acute colitis of any origin
boolean
C3888552 (UMLS CUI [1])
C0017178 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0011991 (UMLS CUI [3])
C0019080 (UMLS CUI [4])
C0009319 (UMLS CUI [5])
Disease Uncontrolled Serious Affecting Investigational Therapy | Communicable Disease Affecting Investigational Therapy | Disease Uncontrolled Serious Affecting Prostatectomy | Communicable Disease Affecting Prostatectomy
Item
any serious uncontrolled medical disorder or active infection which would impair ability to receive study treatment and subsequent prostatectomy
boolean
C0012634 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0392760 (UMLS CUI [1,4])
C0949266 (UMLS CUI [1,5])
C0009450 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0949266 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0205404 (UMLS CUI [3,3])
C0392760 (UMLS CUI [3,4])
C0033573 (UMLS CUI [3,5])
C0009450 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0033573 (UMLS CUI [4,3])
Malignant Neoplasms | Basal cell carcinoma | Squamous cell carcinoma of skin
Item
coexisting malignancies except basal or squamous cell carcinoma of the skin
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial